Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.43 |
| ▸ | MLYCD | O95822 | 3/20 | 0.40 |
| ▸ | LMNA | P02545 | 1/20 | 0.39 |
| ▸ | PGR | P06401 | 1/20 | 0.38 |
| ▸ | AR | P10275 | 1/20 | 0.38 |
| ▸ | MEN1 | O00255 | 4/20 | 0.37 |
| ▸ | KMT2A | Q03164 | 4/20 | 0.37 |
| ▸ | MAPT | P10636 | 4/20 | 0.37 |
| ▸ | SMN1; SMN2 | Q16637 | 3/20 | 0.37 |
| ▸ | MITF | O75030 | 1/20 | 0.37 |
| ▸ | GAA | P10253 | 1/20 | 0.37 |
| ▸ | HPGD | P15428 | 1/20 | 0.37 |
| ▸ | HDAC3 | O15379 | 1/20 | 0.37 |
| ▸ | HDAC11 | Q96DB2 | 1/20 | 0.37 |
| ▸ | HDAC8 | Q9BY41 | 1/20 | 0.37 |
| ▸ | HDAC6 | Q9UBN7 | 1/20 | 0.37 |
| ▸ | EPHX2 | P34913 | 1/20 | 0.37 |
| ▸ | NR1H4 | Q96RI1 | 1/20 | 0.37 |
| ▸ | NPC1 | O15118 | 5/20 | 0.36 |
| ▸ | RAB9A | P51151 | 5/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL17735576 | 0.89 | NPC1 (0.53) | MLYCDLMNAMEN1KMT2ASMN1; SMN2 | |
| SCHEMBL7901436 | 0.83 | ALDH1A1 (0.47) | L3MBTL1LMNAMEN1KMT2AMAPT | |
| SCHEMBL29196079 | 0.83 | MAPK13 (0.47) | L3MBTL1MLYCDLMNAPGRAR | |
| SCHEMBL23682711 | 0.82 | MEN1 (0.39) | L3MBTL1LMNAMEN1KMT2ASMN1; SMN2 | |
| SCHEMBL10031827 | 0.82 | PGR (0.47) | L3MBTL1MLYCDLMNAPGRAR | |
| SCHEMBL1711131 | 0.81 | EPHX2 (0.55) | MEN1KMT2AMAPTSMN1; SMN2MITF | |
| SCHEMBL8284442 | 0.81 | L3MBTL1 (0.45) | L3MBTL1MLYCDLMNAPGRAR | |
| SCHEMBL12883549 | 0.81 | MAPT (0.50) | L3MBTL1LMNAMEN1KMT2AMAPT | |
| SCHEMBL23239821 | 0.81 | KMT2A (0.57) | LMNAMEN1KMT2AMAPTHPGD | |
| SCHEMBL10001145 | 0.79 | L3MBTL1 (0.43) | L3MBTL1MLYCDLMNAPGRAR |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 50 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20230149550-A1 | METHODS AND COMPOUNDS FOR THE TREATMENT OF GENETIC DISEASE | Design Therapeutics, Inc. | 2023-05-18 | — | — | US | disclosed |
| US-20230149550-A1 | METHODS AND COMPOUNDS FOR THE TREATMENT OF GENETIC DISEASE | Design Therapeutics, Inc. | 2023-05-18 | — | — | US | disclosed |
| US-20230144203-A1 | DRUG CONJUGATE OF ERIBULIN DERIVATIVE, PREPARATION METHOD THEREFOR AND APPLICATION THEREOF IN MEDICINE | JIANGSU HENGRUI MEDICINE CO., LTD. (CN) | 2023-05-11 | — | — | US | disclosed |
| US-11209362-B2 | Fluorescent probe for detecting sulfenylated protein, preparation method thereof, and application thereof | CHONGQING MEDICAL UNIVERSITY (CN) | 2021-12-28 | — | — | US | disclosed |
| US-20210238226-A1 | METHODS AND COMPOUNDS FOR THE TREATMENT OF GENETIC DISEASE | Design Therapeutics, Inc. | 2021-08-05 | — | — | US | disclosed |
| US-20210228723-A1 | METHODS AND COMPOUNDS FOR THE TREATMENT OF GENETIC DISEASE | Design Therapeutics, Inc. | 2021-07-29 | — | — | US | disclosed |
| US-10919938-B2 | Modified cyclopentapeptides and uses thereof | Technische Universität München (DE) | 2021-02-16 | — | — | US | disclosed |
| EP-3763766-A1 | LIQUID-CRYSTAL POLYMER, LAMINATED MATERIAL, LIQUID-CRYSTAL POLYMER SOLUTION, AND METHOD OF FORMING LIQUID-CRYSTAL POLYMER FILM | Industrial Technology Research Institute (TW) | 2021-01-13 | — | — | EP | disclosed |
| US-20200323814-A1 | MEDICAL COMPOUND | VERA SALUS RICERCA S.R.L. (IT) | 2020-10-15 | — | — | US | disclosed |
| US-9896668-B2 | Substrate-mimetic AKT inhibitor | UNIVERSITY OF SOUTH FLORIDA (US) | 2018-02-20 | — | — | US | disclosed |
| US-20100145036-A1 | CHEMICAL LINKERS AND CLEAVABLE SUBSTRATES AND CONJUGATES THEREOF | MEDAREX, INC. (US) | 2010-06-10 | — | — | US | disclosed |
| US-20100143368-A1 | Human Antibodies That Bind Cd22 And Uses Thereof | E. R. SQUIBB & SONS, L.L.C. | 2010-06-10 | — | — | US | disclosed |
| US-20100113476-A1 | CHEMICAL LINKERS WITH SINGLE AMINO ACIDS AND CONJUGATES THEREOF | E. R. SQUIBB & SONS, L.L.C. | 2010-05-06 | — | — | US | disclosed |
| US-20100104509-A1 | HUMAN ANTIBODIES THAT BIND CD19 AND USES THEREOF | MEDAREX, INC. (US) | 2010-04-29 | — | — | US | disclosed |
| US-20100092496-A1 | CHEMICAL LINKERS AND CONJUGATES THEREOF | MEDAREX, INC. (US) | 2010-04-15 | — | — | US | disclosed |
| US-20100093973-A1 | POLY(AMINO ACID) COMPOUND HAVING INHIBITORY ACTIVITY ON ABSORPTION OF PHOSPHORUS AND PHOSPHORUS ABSORPTION INHIBITOR | AJINOMOTO CO., INC. (JP) | 2010-04-15 | — | — | US | disclosed |
| US-7691962-B2 | Chemical linkers and conjugates thereof | MEDAREX, INC. (US) | 2010-04-06 | — | — | US | disclosed |
| US-20090162372-A1 | FIBRONECTIN ED-B ANTIBODIES, CONJUGATES THEREOF, AND METHODS OF USE | MEDAREX, INC. (US) | 2009-06-25 | — | — | US | disclosed |
| US-20080279868-A1 | Antibody-Drug Conjugates and Methods of Use | MEDAREX, INC. (US) | 2008-11-13 | — | — | US | disclosed |
| US-7166695-B2 | Affinity markers for human serum albumin | CONJUCHEM BIOTECHNOLOGIES INC. (CA) | 2007-01-23 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (15 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20090162372-A1 | FIBRONECTIN ED-B ANTIBODIES, CONJUGATES THEREOF, AND METHODS OF USE | FN1, EDNRB, EDF1 | L3MBTL1 1918/4885MLYCD 4058/4885LMNA 1466/4885 |
| US-20210238226-A1 | METHODS AND COMPOUNDS FOR THE TREATMENT OF GENETIC DISEASE | ATXN2L, ATXN2, ATXN10 | L3MBTL1 3195/4885MLYCD 3433/4885LMNA 1046/4885 |
| US-20230149550-A1 | METHODS AND COMPOUNDS FOR THE TREATMENT OF GENETIC DISEASE | DMPK, DTYMK, MYCBP | L3MBTL1 429/4885MLYCD 1934/4885LMNA 136/4885 |
| US-20100093973-A1 | POLY(AMINO ACID) COMPOUND HAVING INHIBITORY ACTIVITY ON ABSORPTION OF PHOSPHORUS AND PHOSPHORUS ABSORPTION INHIBITOR | ALPI, SLC7A1, SLC34A1 | L3MBTL1 4197/4885MLYCD 4281/4885LMNA 3506/4885 |
| US-20100113476-A1 | CHEMICAL LINKERS WITH SINGLE AMINO ACIDS AND CONJUGATES THEREOF | DNPEP, ANTXR2, CLSPN | L3MBTL1 255/4885MLYCD 2256/4885LMNA 3365/4885 |
| US-20100143368-A1 | Human Antibodies That Bind Cd22 And Uses Thereof | CD2BP2, CD22, CD2 | L3MBTL1 823/4885MLYCD 4562/4885LMNA 4068/4885 |
| US-20200323814-A1 | MEDICAL COMPOUND | MTNR1B, CBR1, MTNR1A | L3MBTL1 2406/4885MLYCD 3351/4885LMNA 4697/4885 |
| US-20080279868-A1 | Antibody-Drug Conjugates and Methods of Use | CD47, ANTXR2, CD2BP2 | L3MBTL1 1076/4885MLYCD 3306/4885LMNA 2347/4885 |
| US-20210228723-A1 | METHODS AND COMPOUNDS FOR THE TREATMENT OF GENETIC DISEASE | ZFX, F13B, GRN | L3MBTL1 718/4885MLYCD 2641/4885LMNA 188/4885 |
| US-20100104509-A1 | HUMAN ANTIBODIES THAT BIND CD19 AND USES THEREOF | BCL9, BCL9L, BCL6B | L3MBTL1 258/4885MLYCD 3633/4885LMNA 1383/4885 |
| US-20100092496-A1 | CHEMICAL LINKERS AND CONJUGATES THEREOF | CLSPN, CD74, ANTXR2 | L3MBTL1 900/4885MLYCD 3129/4885LMNA 3757/4885 |
| US-20230144203-A1 | DRUG CONJUGATE OF ERIBULIN DERIVATIVE, PREPARATION METHOD THEREFOR AND APPLICATION THEREOF IN MEDICINE | ERLIN1, ERLIN2, EZR | L3MBTL1 4224/4885MLYCD 1652/4885LMNA 3528/4885 |
| US-10919938-B2 | Modified cyclopentapeptides and uses thereof | ANXA4, CPA4, PTMS | L3MBTL1 435/4885MLYCD 3313/4885LMNA 1683/4885 |
| US-11209362-B2 | Fluorescent probe for detecting sulfenylated protein, preparation method thereof, and application thereof | TST, SUMO1, SUMO3 | L3MBTL1 2662/4885MLYCD 3027/4885LMNA 1934/4885 |
| US-20100145036-A1 | CHEMICAL LINKERS AND CLEAVABLE SUBSTRATES AND CONJUGATES THEREOF | XIAP, ADAM8, CLSPN | L3MBTL1 522/4885MLYCD 1583/4885LMNA 1546/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.